PT97583A - Processo para a preparacao de peptidamidas e de composicoes farmaceuticas que as contem uteis como inibidores da coagulacao por fibrina/trombina - Google Patents

Processo para a preparacao de peptidamidas e de composicoes farmaceuticas que as contem uteis como inibidores da coagulacao por fibrina/trombina

Info

Publication number
PT97583A
PT97583A PT97583A PT9758391A PT97583A PT 97583 A PT97583 A PT 97583A PT 97583 A PT97583 A PT 97583A PT 9758391 A PT9758391 A PT 9758391A PT 97583 A PT97583 A PT 97583A
Authority
PT
Portugal
Prior art keywords
amino acid
peptidamides
trombin
fibrin
preparing
Prior art date
Application number
PT97583A
Other languages
English (en)
Other versions
PT97583B (pt
Inventor
Werner Stueber
Karl Fickenscher
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT97583A publication Critical patent/PT97583A/pt
Publication of PT97583B publication Critical patent/PT97583B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97583A 1990-05-08 1991-05-07 Processo para a preparacao de peptidamidas e de composicoes farmaceuticas que as contem uteis como inibidores da coagulacao por fibrina/trombina PT97583B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014655A DE4014655A1 (de) 1990-05-08 1990-05-08 Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren

Publications (2)

Publication Number Publication Date
PT97583A true PT97583A (pt) 1992-02-28
PT97583B PT97583B (pt) 1998-08-31

Family

ID=6405908

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97583A PT97583B (pt) 1990-05-08 1991-05-07 Processo para a preparacao de peptidamidas e de composicoes farmaceuticas que as contem uteis como inibidores da coagulacao por fibrina/trombina

Country Status (13)

Country Link
US (2) US5478810A (pt)
EP (1) EP0456152B1 (pt)
JP (1) JP3090495B2 (pt)
KR (1) KR0181512B1 (pt)
AT (1) ATE172987T1 (pt)
AU (1) AU642733B2 (pt)
CA (1) CA2042001C (pt)
DE (2) DE4014655A1 (pt)
DK (1) DK0456152T3 (pt)
ES (1) ES2125225T3 (pt)
IE (1) IE911548A1 (pt)
NO (1) NO911787L (pt)
PT (1) PT97583B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014655A1 (de) * 1990-05-08 1991-11-14 Behringwerke Ag Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren
DE4133946A1 (de) * 1991-10-14 1993-04-15 Behringwerke Ag Funktioneller test und reagenz zur bestimmung von fibrinogen
DE4242736A1 (de) * 1992-12-17 1994-06-23 Behringwerke Ag Synthetische Peptide, Antikörper dagegen und ihre Verwendung
JP2002525382A (ja) * 1998-09-25 2002-08-13 ザ チルドレンズ メディカル センター コーポレイション プロテインキナーゼの活性を選択的に調節するショートペプチド
MXPA02001349A (es) * 1999-08-09 2002-07-22 Tripep Ab Inhibidores de la polimerizacion de proteinas y metodos de uso.
US6258932B1 (en) * 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
CA2383086A1 (en) 1999-09-08 2001-03-15 Joseph P. Steiner Non-peptidic cyclophilin binding compounds and their use
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US6908899B2 (en) * 2001-08-17 2005-06-21 U.S. Dept. Of Veterans Affairs Pro-inflammatory fibrinopeptide
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
EP1425296B1 (de) 2001-09-10 2011-04-13 Novel Science International GmbH Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
EP1436317A1 (en) * 2001-09-19 2004-07-14 Tripep Ab Molecules that block viral infectivity and methods of use thereof
KR20050101221A (ko) * 2003-02-21 2005-10-20 트리펩 아베 Ｈｉｖ 복제의 억제를 위한 글리신아미드 유도체
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
DE102004059055A1 (de) 2004-12-07 2006-06-08 Dade Behring Marburg Gmbh Verfahren zur automatischen Bestimmung des endogenen Thrombinpotenzials
AU2005321628A1 (en) * 2004-12-29 2006-07-06 Labo Cosprophar Ag Cosmetic composition for skin application suitable for relaxing expression wrinkles
DE102005003145B4 (de) * 2005-01-21 2006-10-19 Dade Behring Marburg Gmbh Stablies, chromogenes Flüssigreagenz und dessen Verwendung in gerinnungsdiagnostischen Tests
US7442323B2 (en) * 2006-06-02 2008-10-28 E. I. Du Pont De Nemours And Company Potassium monopersulfate solutions
AU2007305268A1 (en) * 2006-10-02 2008-04-10 The Board Of Trustees Of The Leland Stanford Junior University Peptides derived from the C2 domain of epsilon PKC, and use thereof
DE102009048199A1 (de) 2009-10-05 2011-04-21 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Bestimmung von Faktor XIII mit Hilfe von Referenzmaterial auf Plasmabasis
DE102009048198A1 (de) 2009-10-05 2011-04-21 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Bestimmung von Faktor XIII mittels NAD(P)H-Analoga
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
EP2395354A1 (de) 2010-06-10 2011-12-14 Siemens Healthcare Diagnostics Products GmbH Homogener Aktivitätstest zur Bestimmung von enzymatischen Reaktionen
EP2465941A1 (de) 2010-12-20 2012-06-20 Siemens Healthcare Diagnostics Products GmbH Verfahren zur simultanen Bestimmung mehrerer Gerinnungsproteasen
EP2471945A1 (de) 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung von Inhibitoren der Gerinnung
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
JP7359538B2 (ja) * 2018-12-07 2023-10-11 株式会社エイアンドティー フィブリノゲン測定試薬
JP7410652B2 (ja) * 2019-04-12 2024-01-10 株式会社エイアンドティー フィブリノゲンの定量方法
US20220120768A1 (en) * 2018-12-07 2022-04-21 A&T Corporation Reagent for measuring fibrinogen
CN110669126B (zh) * 2019-10-23 2022-08-16 广州领晟医疗科技有限公司 多肽gpr5及其促进肝细胞增殖和抑制肝细胞凋亡的用途
CN112206307B (zh) * 2020-09-15 2023-12-05 广州领晟医疗科技有限公司 一种可注射的温敏型水凝胶及其制备方法与应用
EP4239338A1 (de) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Globaltest zur feststellung des status des blutgerinnungssystems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811647A1 (de) * 1988-04-07 1989-10-26 Behringwerke Ag Verfahren und verpackung enthaltend mittel zur kinetischen bestimmung von faktor xiii
DE4014655A1 (de) * 1990-05-08 1991-11-14 Behringwerke Ag Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren

Also Published As

Publication number Publication date
ES2125225T3 (es) 1999-03-01
NO911787D0 (no) 1991-05-07
CA2042001A1 (en) 1991-11-09
US5607858A (en) 1997-03-04
JP3090495B2 (ja) 2000-09-18
IE911548A1 (en) 1991-11-20
KR910020031A (ko) 1991-12-19
AU7622291A (en) 1991-11-14
KR0181512B1 (ko) 1999-04-01
EP0456152A3 (en) 1992-07-22
DK0456152T3 (da) 1999-07-19
EP0456152B1 (de) 1998-11-04
CA2042001C (en) 2002-01-08
AU642733B2 (en) 1993-10-28
US5478810A (en) 1995-12-26
ATE172987T1 (de) 1998-11-15
PT97583B (pt) 1998-08-31
DE4014655A1 (de) 1991-11-14
EP0456152A2 (de) 1991-11-13
JPH0789990A (ja) 1995-04-04
DE59109067D1 (de) 1998-12-10
NO911787L (no) 1991-11-11

Similar Documents

Publication Publication Date Title
PT97583A (pt) Processo para a preparacao de peptidamidas e de composicoes farmaceuticas que as contem uteis como inibidores da coagulacao por fibrina/trombina
BR9406613A (pt) Composto éster ou amida metabolicamente lábil do mesmo processo para a preparação de um composto e composição farmacêutica
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
OA06421A (fr) Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
NO982976D0 (no) N-acylaminoalkylhydrazinkarboksimidamider
ATE61567T1 (de) Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern, verwendung zur synthese von carboxyalkyldipeptiden.
EA200300678A1 (ru) Пептиды и/или белки, а также их применение для получения терапевтической и/или профилактической фармацевтической композиции
BR9803914A (pt) Lantibióticos relacionados a actagardina e processos para sua preparação e uso.
MX9302327A (es) Aminoacidos ciclicos novedosos y derivados de los mismos.
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
DE3854266D1 (de) Verfahren zur Modifizierung eines Molekularsiebes.
ATA298086A (de) Verfahren zur herstellung von neuen cystinverbindungen und deren verwendung
ATE80380T1 (de) Diastereoselektives verfahren zur herstellung von zwischenprodukten verwendbar zur peptidderivatensynthese.
DE69526462D1 (de) Verfahren zur Herstellung von Peptiden aus N-Carboxyanhydridaminosäuren
FR2622578B1 (fr) Nouveaux derives de l'acide aminopimelique, leur procede de preparation et leur application comme medicaments
DE3586752D1 (de) Verfahren zur herstellung wundheilungsfoerdernder praeparationen und solche praeparationen.
DE69428401D1 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese
ES2115535B1 (es) Procedimiento para la preparacion de amidas de d-(-)-aminoacidos.
ATE105300T1 (de) Peptidderivate und verfahren zu deren herstellung.
DE68909451D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EE200200362A (et) Diasepiinkarboksamiidi derivaadid, nende valmistamine ja kasutamine ravimitena ning neid sisaldavadfarmatseutilised kompositsioonid
DE69007877D1 (de) Acrylamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten und deren Verwendung in der Medizin.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911009

FG3A Patent granted, date of granting

Effective date: 19980519

PC3A Transfer or assignment

Free format text: 19981125 BEHRING DIAGNOSTICS GMBH DE

PD3A Change of proprietorship

Owner name: DADE BEHRING MARBURG GMBH

Effective date: 19981125

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20011130